Skip to content

Predicting Success of High Flow Nasal Cannula in Patients with Acute Hypoxemic Respiratory Failure: The Utility of the Non-Invasive Ventilation Test

Predicting Success of High Flow Nasal Cannula in Patients with Acute Hypoxemic Respiratory Failure: The Utility of the Non-Invasive Ventilation Test

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100046461
Enrollment
Unknown
Registered
2021-05-16
Start date
2021-05-13
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Hypoxemic Respiratory Failure

Interventions

HFNC success group vs.HFNC failure group:Nil

Sponsors

Zhongda Hospital, School of Medicine, Southeast University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years and 25 times/min; (2)Patients with oxygen flow >= 10L/min, P/F<= 300mmHg and PaCO2 <= 45mmHg; 3. Signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe asthma or chronic respiratory failure (including chronic obstructive pulmonary disease or other underlying chronic respiratory disease); 2. Hemodynamic instability, SBP15µg/kg/min, noradrenaline >15 ug/min); 3. Cardiogenic pulmonary edema; 4. Severe granulocytopenia (< 500/mm3) and hematologic malignancies; 5. Glasgow Coma Scale score <= 12; 6. Due to nosebleed, recent nasal surgery or other reasons, the high-flow oxygen therapy catheter cannot be used through the nose; 7. Noninvasive ventilation contraindications: facial, neck and oropharyngeal trauma, burns, deformity or recent surgery;Upper respiratory tract obstruction;Diseases with high risk of aspiration, such as vomiting and gastrointestinal bleeding;Recent major esophagus and upper abdominal surgery. 8. Immediate endotracheal intubation is required (life-threatening hypoxemia PaO2/FiO2<50mmHg, cardiac or respiratory arrest, etc.), refused endotracheal intubation, and refused to participate in the study; 9. Patients who will be selectively intubated for diagnosis or treatment (fiberoptic bronchoscopy, surgery, etc.); 10. Patients who are currently participating in other studies.

Design outcomes

Primary

MeasureTime frame
Intubation rate in ICU;

Countries

China

Contacts

Public ContactChen Dongyu

Zhongda Hospital, School of Medicine, Southeast University

15366103007@163.com+86 13813221014

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026